Board of Directors
Dr. Alan Kersey
Dr. Alan Kersey has been engaged in sensor technology research and commercialization for the past 3 decades. His research work began in 1981 at the University of Kent, which was followed by a 14 year tenure at the Naval Research Laboratory (NRL) in Washington DC. At NRL his focus on advanced fiber optic based sensing concepts, led to some of the seminal research on Bragg grating sensor systems.
In 1997, Alan joined a start-up, CiDRA, as it’s founding Chief Technology Officer, to develop fiber Bragg grating sensors for the Oil & Gas industry. He served on CiDRA’s board from 2001 to 2003. From 2003 to 2005, he was CEO of CyVera, a spin-out from CiDRA which developed a genetic analysis/assay platform – BeadXpress. Just prior to the commercial launch of the platform, CyVera was acquired by the leading genetic sequencing company, Illumina. Following this acquisition, Alan was VP & General Manager of Illumina’s division based in Cambridge, UK. Most recently, he re-joined CiDRA in an M&A role, to bring new sensor technologies to the suite the company has already developed & successfully deployed in industrial applications.
Currently Alan serves as a Non-Executive Director on the Board of Industrial Tomography Systems (ITS) in the UK, and as a member of the Technical Advisory Boards of Insight Photonics, and Taff Optical. He is also currently engaged in the formation of several new biotech start-ups in Connecticut under a new entity CyOmics LLC.
Alan holds a B.Sc in Physics & Electronics at the University of Warwick, a Ph.D from the University of Leeds, and is a Fellow of the Optical Society of America. He has published extensively in journal and conference forums, and holds over 100 patents in optical sensing and instrumentation.
Patrick leads CI investments in the clean technology, industrial/energy technologies, life sciences, software and digital media sectors.
Previously, Patrick was a project manager for the Connecticut Clean Energy Fund’s On-Site Renewable Distributed Generation Program and Project 100. He provided financial analysis on renewable energy projects that utilized diverse technologies, including fuel cells, solar photovoltaics, and hydro and sustainable biomass. Patrick’s experience also includes tenures at UTC Power, Duke Engineering and Services (now Areva NP Inc.) and Yankee Atomic Electric Corporation.
Patrick holds a B.S. in Nuclear Engineering, University of Massachusetts at Lowell, an M.S., Mechanical Engineering from Worcester Polytechnic Institute and an M.B.A. in Finance from New York University Stern School of Business. He is also a licensed engineer in the state of Connecticut.
Dean is currently the President & CEO of MHI Medical a contract manufacturer of medical components and devices with expertise in plastics, metal forming, cutting , finishing, assembly and packaging.
Previously, Dean was President & CEO of ETE Medical. ETE Medical was a contract manufacturer that developed and manufactured medical components, subassemblies and assemblies for major medical device OEMs focused on the cardiovascular and orthopedic markets. During Dean’s tenure, ETE achieved annual double-digit plus sales growth and developed a new product pipeline which enabled the company to enter new markets. Additionally, under Dean’s leadership, ETE executed several successful bolt-on acquisitions such as Modified Polymer Components.
Prior to ETE, Dean served as the CEO, President and COO of Memry Corporation, a public company that was traded over the American Stock Exchange until its sale to Sae Getters. Memry was a contract manufacturer that specialized in nitinol products, extrusions and assemblies for the cardiovascular, orthopedic and neurological markets. While at Memry, Dean led the implementation of a Lean Manufacturing program, the integration of Putnam Plastics and the development of a robust new product pipeline program. This resulted in a 3x growth in sales over an 8+ year period.
Dean has 15+ years in the medical device industry and holds a BA and MBA from Lewis University in Lockport, Illinois. He holds a CPIM certification.
Ed Ross, President and Chief Executive Officer
Ed leads ReadyDock as President and Chief Executive Officer since July 2017. Complementing his passion to improve infection prevention, having suffered family losses to healthcare-acquired infections, Ed brings extensive experience in building businesses in executive operational responsibilities across innovative medical device and biologic innovations with emerging companies including ConforMIS, Guided Surgery Solutions, ClozeX Medical (3M) and Gliatech as well as with established market players including Zimmer, Anika Therapeutics and American Hospital Supply Corporation (Baxter/Allegiant). Beyond organic and partnered growth achievements, Ed has led the commercial and business development efforts resulting in successful sale and public offerings of various medtech concerns. Ed earned an M.B.A. from University of Rochester and a B.A. from Dickinson College.
David Engelhardt, Founder and Executive Vice President
David has over 30 years of experience in software and hardware solutions development in healthcare and manufacturing, with a particular focus on mobile technologies including tablets and handheld data collection devices. David is the Founder and EVP of ReadyDock Inc. He is passionate and committed to providing safe, and workflow efficient methods to enable clinicians and patients to enhance care through the use of innovative technologies. He was awarded a patent on the ReadyDock technology platform combining essential workflow and disinfection into a single process. In the small window of time when he is not working or spending time with his amazing wife and daughter, he spends his time playing USTA tennis, collecting vinyl records, and shaping music and sound in his recording studio.